^
    Back
    Association details:
    Biomarker:No biomarker
    Cancer:Germ Cell Tumors
    Regimen:VeIP (cisplatin + ifosfamide + vinblastine)
    Direction:Sensitive
    Evidence:
    Evidence Level:
    Sensitive: A2 - Guideline
    New
    Source:
    NCCN
    Excerpt:
    Testicular Cancer - Nonseminoma…Post Chemotherapy Management…Preferred Regimens…VeIP=Vinblastine/Ifosamide/Cisplatin...
    Evidence Level:
    Sensitive: A2 - Guideline
    New
    Source:
    NCCN
    Excerpt:
    Testicular Cancer - Nonseminoma…Second-line therapy…Preferred Regimens…VeIP=Vinblastine/Ifosamide/Cisplatin...
    Evidence Level:
    Sensitive: A2 - Guideline
    New
    Source:
    NCCN
    Excerpt:
    Second-line Chemotherapy Regimens for Metastatic Germ Cell tumors…Conventional-Dose Chemotherapy Regimens…VeIP…Vinblastine…Ifosamide...Cisplatin…
    Evidence Level:
    Sensitive: A2 - Guideline
    New
    Source:
    NCCN
    Excerpt:
    Malignant Germ cell tumors…Recurrence therapy…Other recommended Regimens…VeIP (Vinblastine, ifosamide, cisplatin)